Cogent Biosciences, Inc. (COGT) Return on equity 2019–2021
Cogent Biosciences, Inc. (COGT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-30.8%FY2021 · since FY2019: -52.8% → -30.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -30.8% | +204.7 pp |
| FY2020 | -235.5% | -182.7 pp |
| FY2019 | -52.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice